Zhang Fuqiang, Hao Feng, An Dong, Zeng Linlin, Wang Yi, Xu Xuemin, Cui Mei-Zhen
From the Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee 37996 and the Department of Regenerative Medicine, College of Pharmacy, and.
From the Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee 37996 and.
J Biol Chem. 2015 Mar 27;290(13):8232-42. doi: 10.1074/jbc.M114.623074. Epub 2015 Jan 26.
Platelet-derived growth factor (PDGF), a potent chemoattractant, induces cell migration via the MAPK and PI3K/Akt pathways. However, the downstream mediators are still elusive. In particular, the role of extracellular mediators is largely unknown. In this study, we identified the matricellular protein Cyr61, which is de novo synthesized in response to PDGF stimulation, as the key downstream mediator of the ERK and JNK pathways, independent of the p38 MAPK and AKT pathways, and, thereby, it mediates PDGF-induced smooth muscle cell migration but not proliferation. Our results revealed that, when Cyr61 was newly synthesized by PDGF, it was promptly translocated to the extracellular matrix and physically interacted with the plasma membrane integrins α6β1 and αvβ3. We further demonstrate that Cyr61 and integrins are integral components of the PDGF signaling pathway via an "outside-in" signaling route to activate intracellular focal adhesion kinase (FAK), leading to cell migration. Therefore, this study provides the first evidence that the PDGF-induced endogenous extracellular matrix component Cyr61 is a key mediator in modulating cell migration by connecting intracellular PDGF-ERK and JNK signals with integrin/FAK signaling. Therefore, extracellular Cyr61 convergence with growth factor signaling and integrin/FAK signaling is a new concept of growth factor-induced cell migration. The discovered signaling pathway may represent an important therapeutic target in growth factor-mediated cell migration/invasion-related vascular diseases and tumorigenesis.
血小板衍生生长因子(PDGF)是一种有效的趋化因子,通过丝裂原活化蛋白激酶(MAPK)和磷脂酰肌醇-3激酶/蛋白激酶B(PI3K/Akt)信号通路诱导细胞迁移。然而,其下游介质仍不明确。特别是,细胞外介质的作用在很大程度上尚不清楚。在本研究中,我们确定了基质细胞蛋白Cyr61,它是在PDGF刺激下重新合成的,作为细胞外信号调节激酶(ERK)和应激活化蛋白激酶(JNK)信号通路的关键下游介质,独立于p38 MAPK和AKT信号通路,从而介导PDGF诱导的平滑肌细胞迁移而非增殖。我们的结果表明,当Cyr61由PDGF重新合成时,它会迅速转运至细胞外基质,并与质膜整合素α6β1和αvβ3发生物理相互作用。我们进一步证明,Cyr61和整合素是PDGF信号通路的重要组成部分,通过“由外向内”的信号途径激活细胞内粘着斑激酶(FAK),从而导致细胞迁移。因此,本研究首次证明,PDGF诱导的内源性细胞外基质成分Cyr61是通过将细胞内PDGF-ERK和JNK信号与整合素/FAK信号联系起来调节细胞迁移的关键介质。因此,细胞外Cyr61与生长因子信号以及整合素/FAK信号的汇聚是生长因子诱导细胞迁移的新概念。所发现的信号通路可能代表了生长因子介导的细胞迁移/侵袭相关血管疾病和肿瘤发生中的一个重要治疗靶点。